Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2015-03-20

FDA Approved: OMEPRAZOLE — Supplemental Application (Apotex Corp)

View source ↗

Summary

FDA approved a supplemental application for omeprazole from Apotex Corp., authorizing a generic version of the drug.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Omeprazole (Omeprazole)

Snippet

SUPPL AP for OMEPRAZOLE (OMEPRAZOLE)